文献速递血液净化与透析

维持性血液透析患者认知障碍筛查测试的评估

Evaluation of Screening Tests for Cognitive Impairment in Patients Receiving Maintenance Hemodialysis.
PubMed 文献 · J Am Soc Nephrol · 2020-03-04

该研究在150例维持性血液透析患者中,以综合神经认知测试为参照,评估6种筛查工具识别重度认知障碍的能力。蒙特利尔认知评估(MoCA)预测能力最高(AUC 0.81),评分≤21时敏感度86%、特异度55%,阴性预测值91%。

要点

  • MoCA对透析患者重度认知障碍筛查性能最佳,AUC为0.81。
  • MoCA评分≤21时敏感度86%、特异度55%,阴性预测值91%。
  • Trail Making Test B和Digit Symbol测试表现尚可,AUC分别为0.73和0.78。

核心结论

  • 蒙特利尔认知评估在维持性血液透析患者中检测重度认知障碍具有高敏感度和中等特异度。

研究设计与样本

  • 2015至2018年纳入150例维持性血液透析患者,进行包括记忆、注意和执行功能的综合神经认知测试以分类认知状态。
  • 采用曲线下面积(AUC)分析评估6种筛查测试识别重度认知障碍的预测能力。

主要发现

  • 150例参与者中21%认知功能正常,17%轻度障碍,33%中度障碍,29%重度障碍。
  • 蒙特利尔认知评估对重度认知障碍的总体预测能力最高,AUC为0.81。
  • 蒙特利尔认知评估评分≤21时,检测重度障碍的敏感度为86%、特异度为55%,阴性预测值为91%。
  • Trail Making Test Part B和Digit Symbol Substitution Test的AUC分别为0.73和0.78。
  • 其他测试的预测性能较低。

关键数值与推荐

  • 蒙特利尔认知评估评分≤21判定重度认知障碍:敏感度86%、特异度55%、阴性预测值91%。
  • Trail Making Test Part B的AUC为0.73,Digit Symbol Substitution Test的AUC为0.78。

临床怎么用

  • 可选用蒙特利尔认知评估对维持性血液透析患者进行重度认知障碍筛查,其高阴性预测值有助于排除重度障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neurocognitive testing shows that cognitive impairment is common among patients receiving maintenance hemodialysis. Identification of a well performing screening test for cognitive impairment might allow for broader assessment in dialysis facilities and thus optimal delivery of education and medical management. METHODS: From 2015 to 2018, in a cohort of 150 patients on hemodialysis, we performed a set of comprehensive neurocognitive tests that included the cognitive domains of memory, attention, and executive function to classify whether participants had normal cognitive function versus mild, moderate, or severe cognitive impairment. Using area-under-the-curve (AUC) analysis, we then examined the predictive ability of the Mini Mental State Examination, the Modified Mini Mental State Examination, the Montreal Cognitive Assessment, the Trail Making Test Part B, the Mini-Cog test, and the Digit Symbol Substitution Test, determining each test's performance for identifying severe cognitive impairment. RESULTS: Mean age was 64 years; 61% were men, 39% were black, and 94% had at least a high-school education. Of the 150 participants, 21% had normal cognitive function, 17% had mild cognitive impairment, 33% had moderate impairment, and 29% had severe impairment. The Montreal Cognitive Assessment had the highest overall predictive ability for severe cognitive impairment (AUC, 0.81); a score of ≤21 had a sensitivity of 86% and specificity of 55% for severe impairment, with a negative predictive value of 91%. The Trails B and Digit Symbol tests also performed reasonably well (AUCs, 0.73 and 0.78, respectively). The other tests had lower predictive performances. CONCLUSIONS: The Montreal Cognitive Assessment, a widely available and brief cognitive screening tool, showed high sensitivity and moderate specificity in detecting severe cognitive impairment in patients on maintenance hemodialysis.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Drew DA, Tighiouart H, Rollins J, et al. Evaluation of Screening Tests for Cognitive Impairment in Patients Receiving Maintenance Hemodialysis. J Am Soc Nephrol. 2020. PMID: 32132197. doi:10.1681/ASN.2019100988

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。